HUP0102861A2 - Attenuált lóherpeszvírus - Google Patents

Attenuált lóherpeszvírus

Info

Publication number
HUP0102861A2
HUP0102861A2 HU0102861A HUP0102861A HUP0102861A2 HU P0102861 A2 HUP0102861 A2 HU P0102861A2 HU 0102861 A HU0102861 A HU 0102861A HU P0102861 A HUP0102861 A HU P0102861A HU P0102861 A2 HUP0102861 A2 HU P0102861A2
Authority
HU
Hungary
Prior art keywords
ehv
mutant
equine herpesvirus
herpesvirus
well
Prior art date
Application number
HU0102861A
Other languages
English (en)
Inventor
Cherida Rachel Dhore
Paulus Jacobus Antonius Sondermeijer
Nicolaas Visser
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of HUP0102861A2 publication Critical patent/HUP0102861A2/hu
Publication of HUP0102861A3 publication Critical patent/HUP0102861A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16411—Rhadinovirus, e.g. human herpesvirus 8
    • C12N2710/16461—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány tárgyát egy lóherpeszvírus (<Equine herpesvirus<; EHV)mutáns képezi, valamint a találmány szerinti mutáns alkalmazásavakcinában, továbbá mutáns EHV-szekvenciát hordozó DNS-szekvenciák ésvektorok, a vektorokkal transzfektált gazdasejtek, valamint eljárásokáltalánosságban EHV, közelebbről, EHV-1 attenuálására. A találmányszerinti megoldás alkalmas lóherpesz megbetegedések megelőzésére. Ó
HU0102861A 1998-07-31 1999-07-26 Attenuated equine herpesvirus HUP0102861A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98202594 1998-07-31
PCT/EP1999/005476 WO2000008165A1 (en) 1998-07-31 1999-07-26 Attenuated equine herpesvirus

Publications (2)

Publication Number Publication Date
HUP0102861A2 true HUP0102861A2 (hu) 2001-11-28
HUP0102861A3 HUP0102861A3 (en) 2005-03-29

Family

ID=8234001

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102861A HUP0102861A3 (en) 1998-07-31 1999-07-26 Attenuated equine herpesvirus

Country Status (9)

Country Link
US (1) US7060282B1 (hu)
EP (1) EP1100925B1 (hu)
AT (1) ATE316139T1 (hu)
AU (1) AU758604B2 (hu)
BR (1) BR9912626B1 (hu)
CA (1) CA2337965C (hu)
DE (1) DE69929530T2 (hu)
HU (1) HUP0102861A3 (hu)
WO (1) WO2000008165A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129722A1 (en) 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh gM-negative EHV-mutants
US7906311B2 (en) * 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
AR040601A1 (es) 2002-07-19 2005-04-13 Boehringer Ingelheim Vetmed Mutantes ehv negativos de gm sin elementos heterologos
WO2005063991A2 (en) 2003-12-19 2005-07-14 Seattle Biomedical Research Institute Live genetically attenuated malaria vaccine
US7722860B2 (en) 2004-12-03 2010-05-25 Seattle Biomedical Research Institute Live genetically engineered protozoan vaccine
CA2708718A1 (en) * 2007-12-21 2009-07-02 Glaxosmithkline Biologicals S.A. Vaccine
CA2732035A1 (en) 2008-07-30 2010-02-04 University Of Kentucky Research Foundation Equine disease model for herpesvirus neurologic disease and uses thereof
EP2629794B1 (en) * 2010-10-18 2017-06-07 Intervet International B.V. Herpesvirus of turkeys vectored vaccine against avian influenza in poultry
AR109539A1 (es) * 2016-09-20 2018-12-19 Boehringer Ingelheim Vetmedica Gmbh Sitio de inserción orf70 de ehv
TW201823467A (zh) 2016-09-20 2018-07-01 德商百靈佳殷格翰維美迪加股份有限公司 犬腺病毒載體
MX2019003160A (es) 2016-09-20 2019-05-27 Boehringer Ingelheim Vetmedica Gmbh Nuevos promotores.
AU2017329654B2 (en) 2016-09-20 2024-04-04 Boehringer Ingelheim Vetmedica Gmbh New swine influenza vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9014951D0 (en) 1990-07-06 1990-08-29 Univ Glasgow Equine herpesvirus-4 tk vaccine
GB9415319D0 (en) 1994-07-29 1994-09-21 Medical Res Council HSV viral vector

Also Published As

Publication number Publication date
CA2337965A1 (en) 2000-02-17
CA2337965C (en) 2009-12-15
US7060282B1 (en) 2006-06-13
WO2000008165A1 (en) 2000-02-17
AU5729399A (en) 2000-02-28
BR9912626B1 (pt) 2010-09-08
BR9912626A (pt) 2001-04-24
EP1100925A1 (en) 2001-05-23
HUP0102861A3 (en) 2005-03-29
ATE316139T1 (de) 2006-02-15
AU758604B2 (en) 2003-03-27
EP1100925B1 (en) 2006-01-18
DE69929530D1 (de) 2006-04-06
DE69929530T2 (de) 2006-07-20

Similar Documents

Publication Publication Date Title
HUP0102861A2 (hu) Attenuált lóherpeszvírus
AU585126B2 (en) Recombinant herpes simplex viruses, vaccines and methods
ATE350467T1 (de) Rekombinantes herpesvirus aus trufhähnen und seine verwendungen
MY117686A (en) Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof
BR9205771A (pt) Vetor de vírus recombinantes e processo para a fabricaçao do mesmo
BR9812232A (pt) Vìrus sincicial respiratório (rsv) humano subgrupo b, isolado, recombinantemente gerado , atenuado, vacina, processo para imunizar um indivìduo para induzir proteção contra o rsv subgrupo b, composição, processo para produzir rsv subgrupo b infeccioso atenuado, e, molécula isolada de ácido nucleico
AUPN477695A0 (en) Gene therapy
AU6489986A (en) Thymidine kinase deletion mutants of bovine herpersvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same
WO2000061736A3 (en) Recombinant and mutant marek&#39;s disease virus
GR3032767T3 (en) Equine herpes viruses (EHV) containing foreign DNA, process for their preparation and their use as vaccines.
ATE288483T1 (de) Nicht-verbreitendes lebendes herpesvirusvakzin
HUP0001991A2 (hu) Varicella Zoster vírus 63-as géntermékkel szembeni vakcinák
EP0256677A3 (en) Pseudorabies virus recombinants and their use in the production of proteins
ATE223492T1 (de) Mutanten des infektiösen rinder rhinotracheitis- virus und impfstoffe
GB2359083A (en) Mutant herpes simplex viruses and uses thereof
ATE160376T1 (de) Dna segment des herpesvirus der marek-krankheit, welches für das glykoprotein ge kodiert
DE69417717D1 (de) Impstoff zum Schutze von Pferden gegen Pferdeherpesvirus-Infektionen
AU8156594A (en) Non-A non-B sequences
WO2002047720A3 (en) Treatment and prevention of ebv infection and ebv-associated disorders
ATE350058T1 (de) Sich gegenseitig schützende herpesviruszusammensetzung und verfahren zur deren herstellung und verwendung
NZ511168A (en) Recombinant CELO virus and CELO virus DNA
HUP9904201A1 (hu) Génterápiában használható, egy exogén nukleinsavat genomjában beépítve tartalmazó rekombináns vírus és egy nem virális és nem plazmid transzfektáló szer kombinációját tartalmazó transzfektáló készítmény
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
Terzić et al. Proportion of CD4a+ CD8a+ and wCD21+ cells in peripheral blood of pigs vaccinated against classical swine fever
MX9708615A (es) Terapia de genes animales.

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: INTERVET INTERNATIONAL B.V., NL

Free format text: FORMER OWNER(S): AKZO NOBEL N.V., NL

FD9A Lapse of provisional protection due to non-payment of fees